Dr Fareeda Barzak completed her BSc (Biochemistry and Genetics), MSc (Biochemistry), and then received her PhD (Biochemistry) in 2020 from the School of Fundamental Sciences, Massey University, Palmerston North. Her PhD research focused on biophysical and biochemical characterisation of DNA-based inhibitors of the cytosine-mutating APOBEC3 enzymes. Specifically, establishing inhibitors to prevent the mutational action of the APOBEC3B enzyme, which enables cancer progression and allows development of drug resistances. Leading to a promising new approach to complement existing anticancer therapies.

Following her PhD, Dr Barzak joined the Riddet Institute as a research technician in 2021 to work on the “FerriPro Technology Transfer” project.